切换至 "中华医学电子期刊资源库"

中华口腔医学研究杂志(电子版) ›› 2010, Vol. 4 ›› Issue (04) : 377 -383. doi: 10.3877/cma.j.issn.1674-1366.2010.04.011

临床研究

口腔矫治器对阻塞性睡眠呼吸暂停综合征合并高血压患者血压的影响
张树标1,(), 王丽萍2, 余伟明1, 罗嘉莹3, 伍颖欣3   
  1. 1.510120 广州医学院第一附属医院口腔科
    2.广州医学院口腔医院修复科
    3.广州医学院第一附属医院广州呼吸疾病研究所睡眠中心
  • 收稿日期:2010-06-12 出版日期:2010-08-01
  • 通信作者: 张树标

The effect of two dimensional adjustable oral appliance therapy on hypertension patients with obstructive sleep apnea-hypopnea syndrom

Shu-biao ZHANG1,(), Li-ping WAN1, Wei-ming YU1, Jia-ying LUO1, Ying-xin WU1   

  1. 1.Department of Stomatology, First Affiliated Houspital of Guangzhou Medical College, Guangzhou 510120, China
  • Received:2010-06-12 Published:2010-08-01
  • Corresponding author: Shu-biao ZHANG
引用本文:

张树标, 王丽萍, 余伟明, 罗嘉莹, 伍颖欣. 口腔矫治器对阻塞性睡眠呼吸暂停综合征合并高血压患者血压的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2010, 4(04): 377-383.

Shu-biao ZHANG, Li-ping WAN, Wei-ming YU, Jia-ying LUO, Ying-xin WU. The effect of two dimensional adjustable oral appliance therapy on hypertension patients with obstructive sleep apnea-hypopnea syndrom[J/OL]. Chinese Journal of Stomatological Research(Electronic Edition), 2010, 4(04): 377-383.

目的

探讨二维可调式口腔矫治器(OA)治疗阻塞性睡眠呼吸暂停综合征(OSAS)合并高血压患者时,对其血压的影响。

方法

106 例确诊为中度OSAS 合并原发性高血压患者,规范口服降压药物治疗3 个月以上,血压控制欠佳,采用二维可调式OA 治疗;75 例能按医嘱坚持OA 治疗6 个月以上为实验组;22 例OA 治疗时间少于三分之一作为对照组;9 例患者间歇性OA 治疗时间大于三分之一,没有纳入研究。 统计分析实验组和对照组OA治疗前后呼吸紊乱指数(RDI)、最低氧饱和度(SaO2)以及平均收缩压(MSBP)、平均舒张压(MDBP)、脉压差(PP)。

结果

实验组RDI、SaO2 均比OA 治疗前明显改善,差异有统计学意义(P <0.05);对照组RDI、SaO2 也比OA 治疗前有改善,但差异无统计学意义(P >0.05)。 实验组MSBP、MDBP 均比OA 治疗前显著下降,血压恢复到正常水平,差异有统计学意义(P <0.05);而对照组MSBP、MDBP 无改善(P >0.05)。 实验组OA 治疗后,PP 有所下降,但与治疗前比较差异无统计学意义(P >0.05);而对照组在6 个月后PP 升高,差异有统计学意义(P <0.05)。 组间比较MSBP、MDBP、PP 三个血压参数:在治疗前实验组与对照组差异均无统计学意义(P >0.05),在治疗后实验组比对照组均有下降,差异均有统计学意义(P <0.05)。

结论

对药物降压治疗效果不理想合并中度OSAS 的高血压患者,二维可调式OA 治疗可有效控制血压。

Objective

The objective of the study was to evaluate the effect of twodimensional adjustable oral appliance (OA) therapy on hypertension patients with obstructive sleep apnea syndrome (OSAS).

Methods

106 patients (62 male and 24 female, mean age: 49 years) diagnosed as moderate OSAS with hypertension were studied before and after insertion of the two-dimensional adjustable oral appliance. Blood pressures of these patients were not effectively controlled after a routine anti-hypertensive drug therapy over three months before the OA therapy. 75 patients who wore OA for 6 months were classified as experimental group. 22 patients who wore OA for less than 1/3 of the 6 months' therapy time because of poorly tolerated were classified as control group. The other 9 patients who wore OA for more than 1/3 of the 6 mouths' therapy time but less than 6 mouths were not included in the study. Statistical analysis was used to evaluate the respiratory disturbance index (RDI), lowest arterial oxygen saturation(SaO2), mean systolic blood pressure (MSBP), mean diastolic blood pressure (MDBP) and pulse pressure (PP) in the two groups.

Results

Significant reduction in the RDI, MSBP, MDBP and significant increase in the lowest arterial oxygen saturation were found after OA therapy for 6 mouths in the experimental group(P <0.05). In the control group, no significant changes were found for these parameters after incomplete OA therapy (P >0.05). After OA therapy for 6 mouths, mild reduction in PP was found in the experimental group, but without significant difference (P >0.05). Significant increases in PP was found in the control group after incomplete OA therapy for 6 mouths (P <0.05). The MSBP, MDBP and PP in the two groups before and after OA therapy were further compared. There was no significant differences (P > 0.05)between the two groups of pre-OA therapy but significant differences (P <0.05) were found between the two groups of post-OA therapy.

Conclusions

It is suggests that two-dimensional adjustable appliance could effectively lower the blood pressure in moderate OSAS patients with hypertension whose blood pressure could not be controlled by anti-hypertensive drug.

图1 二维可调式口腔矫治器
图2 二维可调式口腔矫治器调改 “箭头”表示磨改面
表1 OA 治疗前后睡眠参数(
表2 OA 治疗前后血压参数(mm Hg,
1
Robinson GV, Stradling JR, Davies RJ. Sleep.6:obstructive sleep apnoea/hyponoea syndrome and hypertension. Thorax, 2004,59(12):1089-1094.
2
Butt M, Dwivedi G,Khair O, et al. Obstructive sleep apnea and cardiovascular disease. Int J Cardiol, 2010,139(1):7-16.
3
Bonsignore MR, Zito A. Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk. Arch Physiol Biochem,2008,114(4):255-260.
4
郭素峡,李兴德. 阻塞性睡眠呼吸暂停综合征与高血压靶器官损害. 心血管病学进展, 2008,29(5):727-730.
5
Ringler J, Baxner R, Shannon R, et al. Hypoxemia alone ose not explain blood pressure elevatins after obstructive apneas. J Appl Physiol,1990,69:2143-2148.
6
Svatikova A, Wolk R, Gami AS, et al. Interaction between obstructive sleep apnea and the metabolic syndrome. Curr Diab Rep, 2005,5(1):53-58.
7
Logan AG, Perilikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens,2001,19(12):2271-2277.
8
冯洁美. 持续气道正压通气对阻塞性睡眠呼吸暂停综合征患者高血压的影响. 临床和实验医学杂志, 2009,8(1):105,108.
9
Mayer J, Becker H, Brandenburg U, et al. Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology, 1991,79(2):84-92.
10
Kuramoto E, Kinami S, Ishida Y, et al. Continuous positive nasal airway pressure decreases levels of serum amyloid A and improves autonomic function in obstructive sleep apnea syndrome. Int J Cardiol, 2009,135(3):338-345.
11
Lam B, Sam K, Mok WY, et al. Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax,2007,62(4):354-359.
12
Barnes M, McEvoy RD, Banks S, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea.Am J Respir Crit Care Med, 2004,170(6):656-664.
13
Eskafi M, Ekberg E, Cline C, et al. Use of a mandibular advancement device in patients with congestive hear failure and sleep apnoea.Gerodontology, 2004,21(2):100-107.
14
Ferguson KA, Cartwright R, Rogers R, et al. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep, 2006,29(2):244-262.
15
Almeida FR, Lowe AA. Principles of oral appliance therapy for the management of snoring and sleep disordered breathing. Oral Maxillofac Surg Clin North Am, 2009,21(4):413-420.
16
Cunali PA, Almeida FR, Santos CD, et al. Prevalence of temporomandibular disorders in obstructive sleep apnea patients referred for oral appliance therapy. J Orofac Pain, 2009,23(4):339-344.
17
Giannasi LC, Magini M, Costa MS, et al. Oral appliance treatment for obstructive sleep apnea in a partly edentulous patient. Am J Orthod Dentofacial Orthop,2010,137(4):548-551.
18
Ferguson KA, Ono T, Lowe AA, et al. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax, 1997,52(4):362-368.
19
张树标,罗远明,王丽萍. 二维可调式口腔矫治器治疗阻塞性睡眠呼吸暂停综合征的效果. 广东医学, 2006,27(11):1712-1714.
20
夏晓东,刘道侯,李继武,等. 气道正压通气对阻塞性睡眠呼吸暂停低通气综合征合并高血压患者脉压的影响. 临床肺科杂志, 2008,13(10):49-51.
21
徐江祥,刘志强,黄小红,等. 气道正压通气治疗高血压伴阻塞性睡眠呼吸暂停低通气综合征.中华高血压杂志, 2007,15(1):49-52.
22
Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep, 2004,27(5):934-941.
23
Yoshida K. Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. Int J Prosthodont, 2006,19(1):61-66.
24
Andrén A, Sjöquist M, Tegelberg A, et al. Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance-a three-year follow-up. J Oral Rehabil, 2009,36(10):719-725.
25
Otsuka R, Ribeiro de Almeida F, Lowe AA, et al. The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea. Sleep Breath, 2006,10(1):29-36.
26
O'Rourke M, Frohlich ED. Pulse pressure: Is this a clinically useful risk factor? Hypertension, 1999,34(3):372-374.
27
O'Sullivan RA, Hillman DR, Mateljan R, et al. Mandibular advancement splint: an appliance to treat snoring and obstractive sleep apnea.Am J Respir Crit Care Med, 1995,151(1):194-198.
28
Schmidt-Nowara WW, Meade TE, Hays MB. Treatment of snoring and obstractive sleep apnea with a dental orthosis. Chest, 1991,99(6):1378-1385.
29
高雪梅,曾祥龙,傅民魁,等. 口腔矫治器治疗OSAS 的下颌定位. 口腔正畸学, 2000,7(1):20-22.
30
李巍然,James P McDonald.下颌前移矫正器对阻塞性睡眠呼吸暂停综合征患者上气道影响的X 线研究. 口腔正畸学,2000,7(3):111-114.
[1] 金姗, 丁雪晏, 蔡绮哲, 李一丹, 赵智玲, 郭兮恒, 吕秀章. 左心室压力-应变环对阻塞型睡眠呼吸暂停综合征患者心肌功能的评价[J/OL]. 中华医学超声杂志(电子版), 2023, 20(06): 575-580.
[2] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 刘起帆, 蒋安. 肝硬化门静脉高压症门静脉压力无创测量进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 270-275.
[5] 杨竞, 周光文. 肝硬化门静脉高压症治疗后再出血危险因素分析及预测模型构建[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 296-301.
[6] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[7] 刘国龙, 王鹏, 谭超, 杨辉, 彭菊红. 神经外科机器人辅助双通道颅内血肿清除术治疗高血压性脑出血[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 254-256.
[8] 景方坤, 周建波, 王全才, 黄海韬, 李岩峰, 徐杨熙. 神经导航引导下治疗基底节高血压脑出血的短期疗效预测[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(03): 154-159.
[9] 刘微, 张敏, 解美灵, 喻群群, 周娜, 陈光平, 杨祥, 陈亚丽, 刘梅花. 医院-社区一体化模式在高血压患者管理中的应用效果研究[J/OL]. 中华临床医师杂志(电子版), 2023, 17(11): 1176-1180.
[10] 张洪, 王宏宇. 神经酰胺与心脏和血管疾病关系的研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(11): 1202-1205.
[11] 王亮, 王君, 吕雪白, 袁玉婷, 刘小慧, 张文超. 抗β1肾上腺素受体自身抗体在高血压并左室舒张功能不全中的临床研究[J/OL]. 中华临床医师杂志(电子版), 2023, 17(10): 1040-1044.
[12] 庞宁东, 蒋贻洲, 姜华, 牛传强, 李海波, 刘浪, 刘珍银, 张靖. 经皮腔内血管成形术治疗儿童肾动脉狭窄的疗效及相关因素分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 22-26.
[13] 王梦卉, 王梦茹, 骆秦, 朱晴, 李南方. 高血压及原发性醛固酮增多症患者血清钾及低钾血症与心电图左心室肥大的关系[J/OL]. 中华诊断学电子杂志, 2024, 12(01): 18-24.
[14] 刘鑫, 裴思雨, 李志强, 陈成文, 傅硕, 卢领, 孙楠楠, 程守全, 谢冰, 张诗文, 王诚. 靶向药物联合缺损修复在成人先天性心脏病相关重度肺动脉高压的应用[J/OL]. 中华心脏与心律电子杂志, 2024, 12(02): 86-93.
[15] 王永彬, 贾彦迅, 尹轶广. 神经导航结合3D重建技术引导神经内镜血肿清除术对高血压脑出血患者的影响[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(02): 153-156.
阅读次数
全文


摘要